November 7, 2002
University Of Rochester Medical Center
Doctors have long known that the medications they use to treat prostate cancer effectively for one to two years inevitably fail, leaving patients with few treatment options as the disease progresses, killing more than 30,000 men in the United States alone every year. Now scientists have discovered that at least one such medication has a completely unexpected side effect: The compound actually turns on a molecule known to cause cancerous cells to grow. The work, which earned an award for outstanding research from the American Urological Association, is described in the November 1 issue of the journal Cancer Research.
Scientists have uncovered a cruel twist of fate in men who have advanced prostate cancer.
The above story is based on materials provided by University Of Rochester Medical Center. Note: Materials may be edited for content and length.
Cite This Page:
University Of Rochester Medical Center. "Prostate-Cancer Find Points To New Drug Target." ScienceDaily. ScienceDaily, 7 November 2002. <www.sciencedaily.com/releases/2002/11/021107075715.htm>.
University Of Rochester Medical Center. (2002, November 7). Prostate-Cancer Find Points To New Drug Target. ScienceDaily. Retrieved April 18, 2014 from www.sciencedaily.com/releases/2002/11/021107075715.htm
University Of Rochester Medical Center. "Prostate-Cancer Find Points To New Drug Target." ScienceDaily. www.sciencedaily.com/releases/2002/11/021107075715.htm (accessed April 18, 2014).